Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R M Asquith

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infectionChristopher R M Asquith, Marina L Meli, Lidia S Konstantinova, et al.
Bioorganic Chemistry|May 8, 2026
4-Anilinoquinazoline carbamate derivatization as a platform for prodrug design and localized drug deliveryMabel Barreiro Carpio, Coleman D Walker, Audrey Fikes, et al.
Molecules (Basel, Switzerland)|November 9, 2019
Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK)Christopher R M Asquith, James M Bennett, Lianyong Su, et al.
Chemmedchem|April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor ChemotypeChristopher R M Asquith, Louisa Temme, Michael P East, et al.
Journal of Medicinal Chemistry|April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaChristopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity RelationshipsChristopher R M Asquith, Michael P East, Tuomo Laitinen, et al.
European Journal of Medicinal Chemistry|April 18, 2024
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationshipsChristopher R M Asquith, Michael P East, Tuomo Laitinen, et al.
Molecules (Basel, Switzerland)|May 23, 2018
1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) InhibitorsChristopher R M Asquith, Paulo H Godoi, Rafael M Couñago, et al.
Nature Chemical Biology|October 27, 2022
Small-molecule inhibition of the archetypal UbiB protein COQ8Nathan H Murray, Christopher R M Asquith, Zixiang Fang, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infectionChristopher R M Asquith, Marina L Meli, Lidia S Konstantinova, et al.
Bioorganic Chemistry|May 8, 2026
4-Anilinoquinazoline carbamate derivatization as a platform for prodrug design and localized drug deliveryMabel Barreiro Carpio, Coleman D Walker, Audrey Fikes, et al.
Molecules (Basel, Switzerland)|November 9, 2019
Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK)Christopher R M Asquith, James M Bennett, Lianyong Su, et al.
Chemmedchem|April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor ChemotypeChristopher R M Asquith, Louisa Temme, Michael P East, et al.
Journal of Medicinal Chemistry|April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaChristopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity RelationshipsChristopher R M Asquith, Michael P East, Tuomo Laitinen, et al.
European Journal of Medicinal Chemistry|April 18, 2024
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationshipsChristopher R M Asquith, Michael P East, Tuomo Laitinen, et al.
Molecules (Basel, Switzerland)|May 23, 2018
1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) InhibitorsChristopher R M Asquith, Paulo H Godoi, Rafael M Couñago, et al.
Nature Chemical Biology|October 27, 2022
Small-molecule inhibition of the archetypal UbiB protein COQ8Nathan H Murray, Christopher R M Asquith, Zixiang Fang, et al.
Pageof 6